A recent Defense Department inspector general report revealed that the White House Medical Unit during the Trump administration had improperly given out controlled substances, including to government employees who were not eligible for the service.
The report, released earlier this month, found the medical unit had “severe and systemic problems” with its pharmacy operations, which included the treatment of ineligible employees, prescriptions of controlled substances, and improper record housing of Schedule II drugs such as fentanyl, morphine, and oxycodone.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.